Tg Therapeutics (TGTX) Research & Development: 2016-2025
Historic Research & Development for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $40.9 million.
- Tg Therapeutics' Research & Development rose 102.99% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.9 million, marking a year-over-year increase of 62.63%. This contributed to the annual value of $94.3 million for FY2024, which is 23.75% up from last year.
- As of Q3 2025, Tg Therapeutics' Research & Development stood at $40.9 million, which was up 28.62% from $31.8 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Research & Development registered a high of $63.1 million during Q1 2021, and its lowest value of $14.8 million during Q3 2023.
- In the last 3 years, Tg Therapeutics' Research & Development had a median value of $23.9 million in 2024 and averaged $26.3 million.
- Its Research & Development has fluctuated over the past 5 years, first slumped by 66.97% in 2023, then surged by 106.19% in 2024.
- Over the past 5 years, Tg Therapeutics' Research & Development (Quarterly) stood at $62.6 million in 2021, then slumped by 52.69% to $29.6 million in 2022, then crashed by 41.12% to $17.4 million in 2023, then skyrocketed by 36.82% to $23.9 million in 2024, then soared by 102.99% to $40.9 million in 2025.
- Its Research & Development stands at $40.9 million for Q3 2025, versus $31.8 million for Q2 2025 and $46.4 million for Q1 2025.